资讯

An antibiotic that is commonly used for urinary tract infections effectively treated gonorrhoea, and may even work against ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
In the INDI-UTI study, eligible children were between 3 months and 12 years of age, were febrile (≥38°C) at the time of or ...
77%), regardless of whether the pathogens were susceptible or resistant to amoxicillin-clavulanate. Persistent UTIs occurred in 8 amoxicillin-clavulanate recipients and 1 ciprofloxacin recipient ...
Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials ...